HSBC Holdings’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $288K | Buy |
+26,077
| New | +$372K | ﹤0.01% | 2535 |
|
|
2024
Q2 | – | Sell |
-18,371
| Closed | -$314K | – | 2975 |
|
|
2024
Q1 | $314K | Buy |
+18,371
| New | +$289K | ﹤0.01% | 2418 |
|
|
2023
Q1 | – | Sell |
-10,296
| Closed | -$206K | – | 2732 |
|
|
2022
Q4 | $206K | Buy |
+10,296
| New | +$200K | ﹤0.01% | 2755 |
|
|
2022
Q3 | – | Sell |
-12,395
| Closed | -$244K | – | 2964 |
|
|
2022
Q2 | $244K | Sell |
12,395
-1,416
| -10% | -$37.6K | ﹤0.01% | 2762 |
|
|
2022
Q1 | $441K | Buy |
+13,811
| New | +$387K | ﹤0.01% | 2514 |
|
|
2021
Q4 | – | Sell |
-7,915
| Closed | -$217K | – | 3264 |
|
|
2021
Q3 | $217K | Sell |
7,915
-538
| -6% | -$16.4K | ﹤0.01% | 2742 |
|
|
2021
Q2 | $330K | Buy |
+8,453
| New | +$303K | ﹤0.01% | 2449 |
|
|
2020
Q2 | – | Sell |
-15,000
| Closed | -$155K | – | 2681 |
|
|
2020
Q1 | $155K | Buy |
+15,000
| New | +$420K | ﹤0.01% | 2374 |
|
|
2019
Q4 | – | Sell |
-4,907
| Closed | -$229K | – | 3055 |
|
|
2019
Q3 | $229K | Buy |
+4,907
| New | +$228K | ﹤0.01% | 2792 |
|
|
2019
Q1 | – | Sell |
-4,416
| Closed | -$263K | – | 2727 |
|
|
2018
Q4 | $263K | Buy |
+4,416
| New | +$381K | ﹤0.01% | 2352 |
|
|
2018
Q2 | – | Sell |
-5,755
| Closed | -$623K | – | 2576 |
|
|
2018
Q1 | $623K | Sell |
5,755
-107
| -2% | -$11.8K | ﹤0.01% | 1853 |
|
|
2017
Q4 | $642K | Sell |
5,862
-4,933
| -46% | -$492K | ﹤0.01% | 1431 |
|
|
2017
Q3 | $1.07M | Buy |
10,795
+812
| +8% | +$78.7K | ﹤0.01% | 1470 |
|
|
2017
Q2 | $1.01M | Buy |
9,983
+2,419
| +32% | +$261K | ﹤0.01% | 1457 |
|
|
2017
Q1 | $874K | Buy |
7,564
+1,469
| +24% | +$171K | ﹤0.01% | 1440 |
|
|
2016
Q4 | $731K | Sell |
6,095
-1,035
| -15% | -$115K | ﹤0.01% | 1569 |
|
|
2016
Q3 | $800K | Buy |
7,130
+1,223
| +21% | +$141K | ﹤0.01% | 1411 |
|
|
2016
Q2 | $732K | Buy |
5,907
+211
| +4% | +$25.5K | ﹤0.01% | 1437 |
|
|
2016
Q1 | $640K | Sell |
5,696
-1,426
| -20% | -$148K | ﹤0.01% | 1466 |
|
|
2015
Q4 | $775K | Sell |
7,122
-1,347
| -16% | -$154K | ﹤0.01% | 1537 |
|
|
2015
Q3 | $845K | Buy |
+8,469
| New | +$921K | ﹤0.01% | 1261 |
|
|
2015
Q2 | – | Sell |
-9,658
| Closed | -$1.17M | – | 2092 |
|
|
2015
Q1 | $1.01M | Buy |
9,658
+1,714
| +22% | +$183K | ﹤0.01% | 1347 |
|
|
2014
Q4 | $956K | Buy |
7,944
+1,974
| +33% | +$259K | ﹤0.01% | 1341 |
|
|
2014
Q3 | $874K | Sell |
5,970
-171
| -3% | -$26.4K | ﹤0.01% | 1354 |
|
|
2014
Q2 | $1.03M | Buy |
6,141
+2,563
| +72% | +$456K | ﹤0.01% | 1295 |
|
|
2014
Q1 | $710K | Buy |
3,578
+476
| +15% | +$89.8K | ﹤0.01% | 1313 |
|
|
2013
Q4 | $592K | Buy |
3,102
+823
| +36% | +$153K | ﹤0.01% | 1384 |
|
|
2013
Q3 | $385K | Sell |
2,279
-49
| -2% | -$7.61K | ﹤0.01% | 1449 |
|
|
2013
Q2 | $353K | Buy |
+2,328
| New | +$330K | ﹤0.01% | 1277 |
|
Other funds holding CLB
AI
DGI
CAMG
HSBC Holdings's CLB Position: Q2 2026 in Review
HSBC Holdings opened a new position in Core Laboratories (CLB) in Q2 2026: 26,077 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #2535 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CLB as recently as Q1 2024.
HSBC Holdings first reported a position in CLB in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.07M in Q3 2017. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- HSBC Holdings held 26,077 shares of Core Laboratories worth $288K as of Q2 2026.
- Core Laboratories was a new HSBC Holdings position in Q2 2026.
- Core Laboratories made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2535 holding.
- HSBC Holdings first reported a position in Core Laboratories in Q2 2013 and has held it in 29 quarters since.
- HSBC Holdings's Core Laboratories position peaked at $1.07M in Q3 2017.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.